Skip to main content

Recipient of the 2012 Canada Gairdner Award, Dr. Lorne Babiuk is pictured in the labs at the Katz Group Centre for Pharmacy and Health Research.

Jason Franson for The Globe and Mail/jason franson The Globe and Mail

A Canadian researcher who has dedicated his career to studying infectious diseases in animals and humans and changed the face of vaccine research is being honoured with Canada's top medical prize.

Lorne Babiuk, a Canadian specialist in immunology, virology and vaccinology and vice-president of research at the University of Alberta, is the recipient of the Canada Gairdner Wightman Award, given annually to a Canadian who has shown outstanding leadership in medicine and medical science.

Other top scientists from around the world, including a team that cracked the code of how the human body clock works and an expert whose work in support of vaccines and malaria bed nets has helped reduce childhood deaths, are also recipients of the 2012 Canada Gairdner Awards. The awards are given annually to researchers who have made a significant impact in their field. One of the world's most prestigious medical honours, the Gairdners have an impressive record of choosing recipients who later win the Nobel Prize.

Story continues below advertisement

Dr. Babiuk said one of the main forces driving his work is that disease control and prevention can have a significant impact on society.

"If you look at how devastating infectious diseases are, they've actually shaped societies throughout history," Dr. Babiuk said in an interview. "I could give example after example of how infectious diseases have been controlled by vaccination and if they weren't controlled, it [would have had]huge economic losses, huge morbidity, huge mortality."

Dr. Babiuk demonstrated his commitment to improving vaccine research earlier in his career when he helped found and direct the Vaccine and Infectious Disease Organization at the University of Saskatchewan. On his watch, VIDO grew from a small network into a world leader in research related to areas such as immunology and virology.

Dr. Babiuk was one of a handful of researchers tapped to work on developing a SARS vaccine soon after the outbreak of the illness in 2003.

"I think, without question, Lorne Babiuk has been a leader in studying infections and vaccines to infectious diseases," said Ken Rosenthal, head of the viral vaccines division of the department of pathology and molecular medicine at McMaster University.

One of Dr. Babiuk's crowning achievements came in 2005, when he became one of three Canadian researchers to secure a prestigious Bill and Melinda Gates Grand Challenge in Global Health grant to develop an improved whooping cough vaccine. Children must receive five doses of vaccine to be fully protected, which often doesn't happen in developing countries, where needle shortages and reuse are serious concerns. Dr. Babiuk is using the grant to work on developing a single-dose vaccine that can be delivered up the nose instead of by a needle.





Other winners of the Canada Gairdner Awards include:

Story continues below advertisement

Canada Gairdner International Awards

Jeffrey Hall, professor emeritus of biology at Brandeis University; Michael Rosbash, department of biology, Howard Hughes Medical Institute at Brandeis University; and Michael Young, laboratory of genetics at the Rockefeller University, for the discovery of how the circadian clock regulates human bodies throughout the day.

Thomas Jessell, Howard Hughes Medical Institute, Kavli Institute for Brain Science, Columbia University Medical Center, for determining how sensory neurons communicate with motor neurons in the central nervous system.

Jeffrey Ravetch, Theresa and Eugene Lang professor and head of the Leonard Wagner Laboratory of Molecular Genetics and Immunology at the Rockefeller University, for showing the mechanism by which immune system can harm the body.

Canada Gairdner Global Health Award

Brian Greenwood, London School of Hygiene and Tropical Medicine, for work that has shown vaccines and insecticide-treated bed nets can reduce childhood deaths in developing countries.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter